Pediatric patients with ALL experience, on average, about 15 different symptoms in their chemotherapy journey.

Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.

Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in ...

US drug maker AbbVie has launched its key leukemia drug, Venetoclax, in India, marking its entry into the country's oncology ...

Family and friends of Rachel Simon of Hazlet are staging events to find a bone marrow donor who can help her fight off ...

Researchers have developed drug-delivering aptamers that can deliver a cytotoxic double punch to leukemic stem cells.

A Winnipeg couple has temporarily relocated to Memphis, Tennessee, in search of lifesaving treatment for their 3-year-old son ...